Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20260614069793N1Phase 3Completed
Phase 3, single-blind trial of Althaea officinalis and estradiol in vaginal atrophy (4 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Vaginal maturation index, Vaginal atrophy symptoms and 2 more. Started Aug 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20260614069793N1.